{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:33:50Z","timestamp":1773272030604,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mnm.0b013e3283570fb8","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T13:48:30Z","timestamp":1342878510000},"page":"1077-1080","source":"Crossref","is-referenced-by-count":15,"title":["Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer"],"prefix":"10.1097","volume":"33","author":[{"given":"Armaghan","family":"Fard-Esfahani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Farzanefar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Beiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Saghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Emami-Ardekani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Majdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0001-2998(96)80020-1","article-title":"Radioiodine and thyroid disease: the beginning.","volume":"26","author":"Becker","year":"1996","journal-title":"Semin Nucl Med"},{"key":"R2-12-20210212","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.6004\/jnccn.2010.0094","article-title":"Complications of radioactive iodine treatment of thyroid carcinoma.","volume":"8","author":"Lee","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-12-20210212","first-page":"1551","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.","volume":"39","author":"Alexander","year":"1998","journal-title":"J Nucl Med"},{"key":"R4-12-20210212","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer.","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"key":"R5-12-20210212","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/RLU.0b013e318124fdb6","article-title":"The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma.","volume":"32","author":"Fard-Esfahani","year":"2007","journal-title":"Clin Nucl Med"},{"key":"R6-12-20210212","first-page":"738","article-title":"Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.","volume":"42","author":"Solans","year":"2001","journal-title":"J Nucl Med"},{"key":"R7-12-20210212","first-page":"1519","article-title":"Side effects of rational dose iodine-131 therapy for metastatic well differentiated carcinoma.","volume":"27","author":"Van Nostrand","year":"1986","journal-title":"J Nucl Med"},{"key":"R8-12-20210212","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.2007-1154","article-title":"The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.","volume":"93","author":"Brown","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-12-20210212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1991.261","article-title":"Cancer risks in thyroid cancer patients.","volume":"64","author":"Hall","year":"1991","journal-title":"Br J Cancer"},{"key":"R10-12-20210212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/RLU.0b013e31820a9fe3","article-title":"Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.","volume":"36","author":"Fallahi","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R11-12-20210212","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.IOP.0000117340.41849.81","article-title":"Nasolacrimal obstruction secondary to I-131 therapy.","volume":"20","author":"Burns","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R12-12-20210212","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-002-0969-0","article-title":"Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.","volume":"29","author":"Zettinig","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-12-20210212","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.IOP.0000092802.75899.F8","article-title":"Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.","volume":"19","author":"Shepler","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R14-12-20210212","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/jc.2002-020210","article-title":"Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.","volume":"87","author":"Kloos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-12-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/01676830802225046","article-title":"Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients symptomatology.","volume":"27","author":"Fard-Esfahani","year":"2008","journal-title":"Orbit"},{"key":"R16-12-20210212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.iop.0000179369.75569.a8","article-title":"Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I-131 treated patients.","volume":"21","author":"Morgenstern","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-201210000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:49:33Z","timestamp":1618037373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201210000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3283570fb8","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}